452 related articles for article (PubMed ID: 9563874)
21. Dichotomous role of protein kinase A type I (PKAI) in the tumor microenvironment: a potential target for 'two-in-one' cancer chemoimmunotherapeutics.
Hussain M; Tang F; Liu J; Zhang J; Javeed A
Cancer Lett; 2015 Dec; 369(1):9-19. PubMed ID: 26276720
[TBL] [Abstract][Full Text] [Related]
22. Anti-proliferative effects of 8-chloro-cAMP and other cAMP analogs are unrelated to their effects on protein kinase A regulatory subunit expression.
Lamb D; Steinberg RA
J Cell Physiol; 2002 Aug; 192(2):216-24. PubMed ID: 12115728
[TBL] [Abstract][Full Text] [Related]
23. 8-Cl-cAMP antagonizes mitogen-activated protein kinase activation and cell growth stimulation induced by epidermal growth factor.
Budillon A; Di Gennaro E; Caraglia M; Barbarulo D; Abbruzzese A; Tagliaferri P
Br J Cancer; 1999 Dec; 81(7):1134-41. PubMed ID: 10584873
[TBL] [Abstract][Full Text] [Related]
24. Inhibition of growth and modulation of gene expression in human lung carcinoma in athymic mice by site-selective 8-Cl-cyclic adenosine monophosphate.
Ally S; Clair T; Katsaros D; Tortora G; Yokozaki H; Finch RA; Avery TL; Cho-Chung YS
Cancer Res; 1989 Oct; 49(20):5650-5. PubMed ID: 2676146
[TBL] [Abstract][Full Text] [Related]
25. 8-chloroadenosine 3',5'-monophosphate (8-Cl-cAMP) selectively eliminates protein kinase A type I to induce growth inhibition in c-ras-transformed fibroblasts.
Noguchi K; Murata T; Cho-Chung YS
Eur J Cancer; 1998 Jul; 34(8):1260-7. PubMed ID: 9849489
[TBL] [Abstract][Full Text] [Related]
26. Alteration of type II regulatory subunit of cAMP-dependent protein kinase in human cisplatin-resistant cells as a basis of collateral sensitivity to 8-chloro-cAMP.
Nishio K; Morikage T; Kubota N; Ohmori T; Takeda Y; Fujiwara Y; Miki K; Abe K; Saijo N
Jpn J Cancer Res; 1992 Jul; 83(7):754-60. PubMed ID: 1325432
[TBL] [Abstract][Full Text] [Related]
27. Up-regulated EGF receptors undergo to rapid internalization and ubiquitin-dependent degradation in human cancer cells exposed to 8-Cl-cAMP.
Caraglia M; Di Gennaro E; Barbarulo D; Marra M; Tagliaferri P; Abbruzzese A; Budillon A
FEBS Lett; 1999 Mar; 447(2-3):203-8. PubMed ID: 10214946
[TBL] [Abstract][Full Text] [Related]
28. Dual-agent molecular targeting of the epidermal growth factor receptor (EGFR): combining anti-EGFR antibody with tyrosine kinase inhibitor.
Huang S; Armstrong EA; Benavente S; Chinnaiyan P; Harari PM
Cancer Res; 2004 Aug; 64(15):5355-62. PubMed ID: 15289342
[TBL] [Abstract][Full Text] [Related]
29. 8-Cl-cAMP induces truncation and down-regulation of the RI alpha subunit and up-regulation of the RII beta subunit of cAMP-dependent protein kinase leading to type II holoenzyme-dependent growth inhibition and differentiation of HL-60 leukemia cells.
Rohlff C; Clair T; Cho-Chung YS
J Biol Chem; 1993 Mar; 268(8):5774-82. PubMed ID: 8449943
[TBL] [Abstract][Full Text] [Related]
30. 8-Chloro-cyclic AMP-induced growth inhibition and apoptosis is mediated by p38 mitogen-activated protein kinase activation in HL60 cells.
Ahn YH; Jung JM; Hong SH
Cancer Res; 2005 Jun; 65(11):4896-901. PubMed ID: 15930311
[TBL] [Abstract][Full Text] [Related]
31. Combined epidermal growth factor receptor targeting with the tyrosine kinase inhibitor gefitinib (ZD1839) and the monoclonal antibody cetuximab (IMC-C225): superiority over single-agent receptor targeting.
Matar P; Rojo F; Cassia R; Moreno-Bueno G; Di Cosimo S; Tabernero J; Guzmán M; Rodriguez S; Arribas J; Palacios J; Baselga J
Clin Cancer Res; 2004 Oct; 10(19):6487-501. PubMed ID: 15475436
[TBL] [Abstract][Full Text] [Related]
32. Inhibition of human pancreatic cancer cell (MIA PaCa-2) growth by cholera toxin and 8-chloro-cAMP in vitro.
Ohmura E; Wakai K; Isozaki O; Murakami H; Onoda N; Emoto N; Shizume K; Tsushima T; Demura H; Robins RK
Br J Cancer; 1993 Feb; 67(2):279-83. PubMed ID: 8381655
[TBL] [Abstract][Full Text] [Related]
33. Inhibitory effect of 8-chloro-cyclic adenosine 3',5'-monophosphate on cell growth of gastric carcinoma cell lines.
Takanashi A; Yasui W; Yoshida K; Yokozaki H; Saito D; Abe K; Urakami K; Miki K; Tahara E
Jpn J Cancer Res; 1991 Mar; 82(3):325-31. PubMed ID: 1850725
[TBL] [Abstract][Full Text] [Related]
34. Anti-EGFR monoclonal antibodies and EGFR tyrosine kinase inhibitors as combination therapy for triple-negative breast cancer.
El Guerrab A; Bamdad M; Kwiatkowski F; Bignon YJ; Penault-Llorca F; Aubel C
Oncotarget; 2016 Nov; 7(45):73618-73637. PubMed ID: 27655662
[TBL] [Abstract][Full Text] [Related]
35. 8-Cl-adenosine-induced inhibition of colorectal cancer growth in vitro and in vivo.
Carlson CC; Chinery R; Burnham LL; Dransfield DT
Neoplasia; 2000; 2(5):441-8. PubMed ID: 11191111
[TBL] [Abstract][Full Text] [Related]
36. Epidermal growth factor (EGF) receptor blockade inhibits the action of EGF, insulin-like growth factor I, and a protein kinase A activator on the mitogen-activated protein kinase pathway in prostate cancer cell lines.
Putz T; Culig Z; Eder IE; Nessler-Menardi C; Bartsch G; Grunicke H; Uberall F; Klocker H
Cancer Res; 1999 Jan; 59(1):227-33. PubMed ID: 9892211
[TBL] [Abstract][Full Text] [Related]
37. Response to epidermal growth factor receptor inhibitors in non-small cell lung cancer cells: limited antiproliferative effects and absence of apoptosis associated with persistent activity of extracellular signal-regulated kinase or Akt kinase pathways.
Janmaat ML; Kruyt FA; Rodriguez JA; Giaccone G
Clin Cancer Res; 2003 Jun; 9(6):2316-26. PubMed ID: 12796401
[TBL] [Abstract][Full Text] [Related]
38. Combined blockade of protein kinase A and bcl-2 by antisense strategy induces apoptosis and inhibits tumor growth and angiogenesis.
Tortora G; Caputo R; Damiano V; Bianco R; Fontanini G; Cuccato S; De Placido S; Bianco AR; Ciardiello F
Clin Cancer Res; 2001 Aug; 7(8):2537-44. PubMed ID: 11489837
[TBL] [Abstract][Full Text] [Related]
39. Growth and molecular interactions of the anti-EGFR antibody cetuximab and the DNA cross-linking agent cisplatin in gefitinib-resistant MDA-MB-468 cells: new prospects in the treatment of triple-negative/basal-like breast cancer.
Oliveras-Ferraros C; Vazquez-Martin A; López-Bonet E; Martín-Castillo B; Del Barco S; Brunet J; Menendez JA
Int J Oncol; 2008 Dec; 33(6):1165-76. PubMed ID: 19020749
[TBL] [Abstract][Full Text] [Related]
40. Activation of proteinase-activated receptor 1 promotes human colon cancer cell proliferation through epidermal growth factor receptor transactivation.
Darmoul D; Gratio V; Devaud H; Peiretti F; Laburthe M
Mol Cancer Res; 2004 Sep; 2(9):514-22. PubMed ID: 15383630
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
